| 09h00 |
Welcome and Opening
Conductor: Elvan Böke and Arnau Sebé-Pedrós
- Luis Serrano, Director of the CRG
- Jordi Camí, Director of the PRBB
- Ignasi López, Director of the Relations with Health and Research Institutions Area, 'la Caixa' Foundation
- Laia de Nadal, Rector of the Universitat Pompeu Fabra
- Manel Balcells, Catalan Minister of Health
|
| 09h30 |
CRG 20 years' celebration
- Miguel Beato, Founder and former Director of the CRG
- Andreu Mas-Colell, President of the Barcelona Institute of Science and Technology and former Catalan Minister of Economy of the Government of Catalonia
- Carmen Vela, Director of Collaborative Projects, Gold Standards Diagnostics and former State Secretary of Research, Development and Innovation of the Spanish Government
|
| 10h00 |
Colloquium "The value of fundamental science"
Moderator: Cristina Sáez, science journalist
1st part: Short talks about the successful experience of four local entrepreneurs
- Carlos Buesa, CEO, Oryzon Genomics
- Marie-Eve Beaulieu, cofounder and Chief Scientific Officer of Peptomyc SL, spun out from VHIO
- Maria Lluch, founder and Chief Scientific Offier of Pulmobiotics, spun out from CRG, and CRG Alumni
- Salvador Aznar-Benitah, founder and Scientific Advisor of Ona Therapeutics, spunt out from IRB Barcelona, researcher at IRB Barcelona and CRG Alumni
- Evan Floden, CEO and Co-founder, Seqera Labs, spunt out from CRG, and CRG Alumni
2nd part: Debate with relevant stakeholders in the field of life sciences entrepreneurship
- Maria Leptin, President, European Research Council (ERC)
- Ion Arocena, Director of ASEBIO (Spanish Association of Biotech Companies)
- Carmen Vela, Director of Collaborative Projects, Gold Standards Diagnostics and former State Secretary of Research, Development and Innovation of the Spanish Government
- Jordi Xiol, Partner, Ysios Capital
- Clara Campàs, Managing Partner and Co-founder, Asabys
- Bernhard Paetzold, cofounder and Chief Scienfic Officer of SBiomedic, and CRG Alumni
- Phillip Zamore, HHMI, Chair and Professor at the RNA Therapeutics Institute, University of Massachusetts Medical School, US
- Xavier Aldeguer, Professor at the Universitat de Girona and Researcher at IDIBGI
- Luis Serrano, Director of the CRG
|
| 11h30 |
Coffee break
|
| |
Scientific Talks
Session 1 | Chair: Sara Sdelci |
| 12h00 |
"Mechanism-based antisense therapeutics for genetic diseases and oncology"
Adrian Krainer, Cold Spring Harbor Laboratory, NY, US,
introduced by Fátima Gebauer
|
| 13h00 |
"Understanding cellular reprogramming in vivo"
Manuel Serrano, Cambridge Institute of Science, Altos Labs, Cambridge, UK,
introduced by Bernhard Payer
|
| 14h00 |
Lunch break
|
| |
Sesion 2 | Chair: Nick Stroustrup
|
| 15h00 |
"A single-cell isoform view of mouse and human brain OR progress through 12 years of failure in long-read sequencing."
Hagen Tilgner, Weill Cornell’s The Feil Family Brain and Mind Research Institute, New York, NY, US,
introduced by Roderic Guigó
|
| 15h30 |
"Engineering a bacterial chassis to treat respiratory diseases"
Maria Lluch, Pulmobiotics, Barcelona, Spain,
introduced by Luis Serrano
|
| 16h00 |
"Adventures with Argonautes"
Phillip Zamore, HHMI, RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, US,
introduced by Manuel Irimia
|
| 17h00 |
Coffee break
|
| 17h30 |
Speech by
Laia Arnal, Director General of Knowledge Society, Transfer and Territory, Department of Research and Universities, Government of Catalonia
|
| |
Sesion 3 | Chair: Donate Weghorn
|
| 17h35 |
"Organoids to study regeneration and cancer"
Meritxell Huch, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany,
introduced by Susana de la Luna
|
| 18h00 |
"The Src oncoprotein; from avian model systems to human disease"
Sara A. Courtneidge, Oregon Health & Science University, Portland, OR, US,
introduced by Eva Novoa
|
| 19h00 |
Closing
- Dr. Cristobal Belda, Director of the Instituto de Salud Carlos III, representing the Spanish Ministry of Science and Innovation
|
CRG 20th Anniversary Symposium: The value of fundamental research